Atropine for the treatment of childhood myopia.

By W. Chua, V. Balakrishnan, Y. Chan, L. Tong, Y. Ling, B. Quah, Donald T. Tan. Ophthalmology (Rochester, Minn.), 2006

636 citations recorded by the source corpus.

Subfields: Epidemiology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/a85fe2eb775bbfd4246f8581c1422937c8b5fd74

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Audrey Chia
2. Donald T. Tan
3. Qingshu Lu

In Radiology, Nuclear Medicine and Imaging

1. Audrey Chia
2. Donald T. Tan
3. Qingshu Lu

Citations in the corpus

• Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. (2016, methodology): “5 D).(16,19,20) By combining the 2 studies, we found that in the initial 8 months, there was a hyperopic shift in the 1.”
• Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. (2019, positive): “14 Recently, lower-concentration atropine eye drops have been found to be effective in slowing myopia progression.”